FDG-PET/CT Imaging in Chimeric Antigen Receptor-Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence

Abenavoli, E. M., Linguanti, F., Dercle, L., Berti, V., & Lopci, E. (2024). FDG-PET/CT Imaging in Chimeric Antigen Receptor–Engineered T-Cell Treatment in Patients with B-Cell Lymphoma. PET Clinics. https://doi.org/10.1016/j.cpet.2024.05.006
Authors:
Elisabetta Maria Abenavoli
Flavia Linguanti
Laurent Dercle
Valentina Berti
Egesta Lopci
Affiliated Authors:
Laurent Dercle
Columbia Affiliation:
Author Keywords:
b-cell lymphoma
non-hodgkin lymphoma
car-t
fdg
pet/ct
response
adverse events
elink
Publication Type:
Article
Unique ID:
10.1016/j.cpet.2024.05.006
PMID:
38969565
DOI:
10.1016/j.cpet.2024.05.006
Journal:
PET Clinics
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: